Perspectives
Pharmacist intervention may help identify potential opioid abuse early
Concurrent drug utilization review catches opioid abuse upstream
July 21, 2016Concurrent drug utilization review (DUR) may cast wider net for catching potential opioid abuse upstream
A pharmacist intervention (DUR) may impact potential opioid misuse and abuse. This study identified at-risk members at the time they submit their opioid prescription. A soft edit (point of service) intervention delayed or altered claims for 42% of the members in the study.
Related news
Perspectives
April 25, 2024
Drug Approvals Monthly Update: April 2024
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals…
Perspectives
April 24, 2024
Prime/MRx resident wins AMCP Foundation Best Poster Award
Ai Quynh Nguyen, PharmD, was recently recognized for her research on opioid-prescribing patterns and outcomes
Perspectives
April 23, 2024
Expert Clinical Network Insights: April 2024
A look into our Expert Clinical Network (ECN) – part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access to more than 175 national and world-renowned key opinion leaders in multiple disease categories who provide expertise on challenging prior authorization case reviews, peer-to-peer discussions, drug policy development and formulary guidance